The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by https://U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, vaccination for COVID-19 and Influenza (flu) is mandatory for all MSK staff who do not work 100% remotely (including new hires ). Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical, religious, or fully remote exemption. Requests for exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
Memorial Sloan Kettering Cancer Center (MSK) is one of the world’s premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.
The largest of MSK’s clinical departments, the Department of Medicine (DoM) encompasses experts in solid tumor oncology, hematologic malignancies, subspeciality medicine and supportive and acute care services. Offering a range of services both in multiple sites in New York City and at their suburban outpatient locations in our Regional Care Network (RCN), DoM physicians oversee the care of the whole patient. The RCN serves the areas surrounding Manhattan and extends from Southern New Jersey to Eastern Long Island and brings the same high-level expertise, clinical care, and access to clinical trial protocols that are available at our main campus in New York City.
The Genitourinary Oncology Service in the Division of Solid Tumor Oncology, Department of Medicine at Memorial Sloan Kettering Cancer Center is seeking full-time Academic Clinicians or Clinical Investigators at the Assistant Attending level or higher, focusing on clinical care, research and innovation, and teaching. This position would serve as a hybrid role servicing our Manhattan location at the Sidney Kimmel Center for Prostate and Urologic Cancers, and one of our Regional Network sites (New Jersey, Long Island, Westchester, etc.), or a Regional Network Site only. Our 30 full time Genitourinary Oncologists see patients with a wide range of malignant diseases including prostate cancer, bladder cancer, kidney cancer, and testicular cancer, among others. The Genitourinary Oncology Service also supports a wide range of clinical and translational research. For this position, candidates should have a superb clinical and interpersonal skills, must also be a critical thinker, highly motivated, empathetic, and a team player.
Candidates must be board certified or board eligible in medical oncology.
Please send a CV, a letter outlining your interest and names/contact information of three references vis email to:
Jonathan Rosenberg, MD
Chief, Genitourinary Oncology Service
Enno W. Ercklentz Chair
Memorial Sloan Cancer Center
With copy to Annie Ng, Administrative Assistant